aide

New York City, United States – Mayor Zohran Mamdani is challenging a new law that would give New York City’s teaching aides a one-time $10,000 bonus, arguing it goes against the city’s collective bargaining laws.

On Wednesday, the bill, which was passed by New York City’s City Council, automatically became law because the mayor had opted not to veto it. Instead, Mamdani filed a lawsuit to block it because the City Council had enough votes to override his veto.

The bill, called the Respect Check Act, was backed by the United Federation of Teachers (UFT), a labour union representing teachers across New York City’s public school system and was championed by City Council Speaker Julie Menin, who has often clashed with the mayor.

Teaching assistants are among the lowest-paid workers in the city’s school system, according to a statement released by Menin’s office on Wednesday. Their pay is as low as $32,000. According to MIT’s living wage calculator, the living wage in New York City is $79,469 for Manhattan, $67,558 for Brooklyn, $73,258 for Queens, $67,974 in Staten Island, and $60,341 for the Bronx.

When the bill passed in July, Mamdani argued that the law directly violated a state law called the Taylor Law, a nearly 60-year-old law that gives public sector workers the right to organise. The UFT, which endorsed Mamdani in July 2025 ahead of the city’s election, pushed back on the mayor’s claims. The group argued the City Council did not undermine collective bargaining.

“The City Council would not have introduced – let alone passed – this bill if it were illegal, and we would not have supported a bill that threatened our collective bargaining rights,” Michael Mulgrew, president of the UFT, said in a statement provided to Al Jazeera.

“This moment is an opportunity for Mayor Mamdani to create a new, fairer system and build the kind of city he said he wanted to lead. This administration must keep its promises, and we won’t stop until it does.”

The City Council crafted the law to avoid violating New York’s Taylor Law, a UFT representative told Al Jazeera.

Under a 2023 state appeals court ruling, additional payments to public employees are mandated to be independent of a worker’s regular salary and cannot be tied to collective bargaining, they argue.

“The Court of Appeals has found that the Taylor Law does not prevent a municipality from unilaterally providing an economic benefit,” Beth Norton, general counsel for the UFT, said in testimony in front of the City Council in 2025, provided to Al Jazeera.

Pushing back

New York City Hall sees it differently.

“Council labels these ‘stabilisation’ payments; they effectively function as stipends or salary bonuses and, regardless of terminology, are an additional form of compensation and, as such, a mandatory subject of bargaining,” the 18-page filing obtained by Al Jazeera said.

“I think the mayor is right that this sets a bad precedent,” Adin Lenchner, founder of the New York-based political consultancy Carroll Street Campaigns, told Al Jazeera.

“Him and his team are either posturing, negotiating, or using this as a moment to negotiate toward some other kind of deal. I think everyone would agree that, substantively and philosophically, this is aligned with the mayor’s public policy approach and his vision for the city,” Lenchner added.

“So, if I had to guess, this is, on the one hand, about not wanting to establish a bad precedent and, on the other hand, a step toward a longer-term negotiation.”

Citizens Budget Commission (CBC), a nonpartisan think tank, urged the mayor in July to veto the bill, arguing that City Council should not make this decision. It says the now-law would add $325m in city spending.

“The City should continue to determine employee compensation at the bargaining table, not the legislative chamber,” vice president for research at CBC, Ana Champeny, said in a press release in mid-July.

Mamdani echoed that sentiment when he was asked about the law earlier this month.

“Conversations around compensation are better left at the bargaining table,” Mamdani said in a news conference on August 6.

However, the mayor voiced support on the campaign trail for legislation that would provide support payments to these paraprofessionals. That legislation supported recurring payments, not a one-time payment.

“The version he supported last fall made the payment recurring; what passed last month only guarantees it for one year. That’s the line between then and now, so not much of a flip-flop,” Lenchner added.

“We will not allow the political process to replace the collective bargaining table. The City is filing a lawsuit to protect the right of every union to negotiate on behalf of its members, to fight for the workplace they deserve and ensure that workers – not politicians – determine their own futures,” Matt Rauschenbach, a spokesperson for the mayor, said in a statement provided to Al Jazeera.

“We will work towards a quick resolution that respects workers, protects the City’s finances, and ensures that the Council does not interfere with collective bargaining in the future.”

Rauschenbach declined to provide further comment.

Aug. 20 (UPI) — President Donald Trump has nominated White House aide Dr. Heidi Overton to lead the Food and Drug Administration, drawing anger from Democrats and criticism from a key Republican senator.

Trump announced his nomination of Overton to be the next FDA commissioner on his Truth Social platform Wednesday, calling the deputy director of the White House Domestic Policy Council “a ROCKSTAR in my administration.”

“She is known to take on the HARDEST issues, and bring me solutions that work best for the Country,” Trump said. “We need her leadership at the FDA now to ensure that the U.S. remains the WORLD LEADER for Scientific Discovery and CURES.”

If confirmed by the Senate, Overton will be tasked with overseeing agency policy concerning drugs, vaccines, tobacco products and much of the food supply, among other responsibilities. Kyle Diamantas, a friend of Trump’s son Donald Trump Jr. has been serving as acting FDA commissioner since Marty Makary resigned as head of the agency in May following reported clashes with the Trump administration over its decision to authorize fruit-flavored electronic cigarettes.

“Heidi brings exceptional judgment, professionalism, discipline and an unwavering commitment to the American people,” Department of Health and Human Services Secretary Robert F. Kennedy Jr. said in a statement supporting her nomination to lead the FDA under him.

“I have seen her challenge assumptions, demand excellence and turn bold ideas into meaningful results.”

She has had an increasingly visible presence near the president in recent months and most recently appeared with him earlier this month when he signed an executive order to reduce the number of vaccines recommended for children, which has sparked widespread concern among the medical community.

House Speaker Mike Johnson, R-La., called Overton “a woman of deep faith, an accomplished physician and a champion of the America First agenda” as he congratulated her on the nomination.

“I have seen firsthand her ability to navigate complex policy challenges with conviction and clarity,” he said in a social media statement.

“She will serve our country well.”

While Republicans praised Trump’ pick, Sen. Bill Cassidy, a doctor, broke ranks, saying that while he respected her experience as a physician, “I have strong concerns about her nomination,” citing her lack of managerial experience of a large organization, such as the FDA, which is dealing with staffing and morale issues.

“Additionally, Dr. Overton’s active role in last week’s nonsensical vaccine executive order calls into question her commitment to standing up for sound science and protecting children’s health,” he said online.

“That alone is almost disqualifying.”

Cassidy, who represents Louisiana, will play a key roe in her confirmation as chairman of the Senate Health, Education Labor and Pensions Committee a key vote in whether she is confirmed. Republicans can afford to lose only three votes on the Senate floor, as they only hold a 53-seat majority. The two independent senators caucus with the Democrats, who are all expected to all vote against her nomination.

“Heidi Overton is a far-right, anti-abortion extremist who has no business leading the FDA,” Sen. Patty Murray, D-Wash., said in a statement.

“The American people deserve someone who will put science and facts FIRST, not another Trump sycophant who will make it their mission to attack medication abortion.

“I will vote NO.”

Reproductive health organizations also criticized Trump’s pick, pointing to Overton’s celebration of the overturning of Roe vs. Wade, returning oversight of abortion to the states, as a “huge victory” and to her advocacy for what they described as the politicization of government agencies when she worked at the far-right America First Policy Institute think tank.

“Donald Trump is trying to put an anti-abortion extremist in charge of any agency that could seriously undermine reproductive healthcare — including the agency that could roll back access to mifepristone nationwide,” Reproductive Freedom for All President and CEO Mini Timmaraju said in a statement, referring to a prescription oral medication used to terminate an early pregnancy.

“Her nomination is another alarming step in Trump’s plan to weaponize every part of the federal government to restrict abortion nationwide.”

Dr. Heidi Overton, a top White House aide, has been picked to lead the Food and Drug Administration, President Trump announced Wednesday.

As a medical doctor and deputy director of the White House Domestic Policy Council who has worked on several of Trump’s second-term health initiatives, Overton has become a trusted figure in the administration and a champion of the president’s goals.

Yet any new FDA commissioner will have to balance a raft of competing priorities, between Trump’s fixations, the anti-regulatory interests of traditional Republicans and the anti-corporate posture of Health Secretary Robert F. Kennedy Jr.

Those challenges dogged the tenure of the previous FDA head, Dr. Marty Makary, who resigned in May, leaving behind unfinished projects including work on ultraprocessed foods, antidepressants and COVID-19 shots.

Referring to a “Dr. Heidi” in a Truth Social post, Trump called Overton a smart and respected “rockstar” who would deliver on his priorities of faster cures, innovation, lower drug prices and more wins for Health Secretary Robert F. Kennedy’s Make America Healthy Again movement.

Swenson writes for the Associated Press.